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Digestion of phosphatidylinositol (PI) or glycosylphosphatidylinositol (GPI) anchors of membrane proteins on the external cell surface with 
exogenous PI-specific phospholipasc C (PIPLC) from Buciih~s rlwi~t~hnsh was shown to transmit a signal into the thymocyte to modulate the 
TCFKD3 complex-induced signal delivery for cell activation. This was demonstrated for very early protein tyrosine phosphorylation, early c-&s 
transcription and late DNA synthesis, For this effect preincubation of the cells with PIPLC was required, but there was no evidence of involvement 
of any soluble products released form the cell surface by PIPLC in the signaling, su8gestin8 a crucial role of the mcmbmne-bound counterpart 
(diacylglycerol r diradylglycerol) of the PIlGPI hydrolysntc. A possible role for this accessory signal in the microorganism-linked control of the 
T cell receptor function is discussed. 
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1. INTRODUCTION 
An increasing number of proteins are being reported 
as inserting int.o the cell membrane with a common 
glycosylphosphatidylinositol (GPI) anchor [l-3]. They 
include Thy-l [4-63, TAP (Ly-6A.2) [7] and Qa-2 [8], 
and share an activity to transduw a signal for cell acti- 
vation [5-S] which might be primarily linked to the GPI 
anchor rather than to protein moieties. Yet the molecu- 
lar basis of the potentially unique pathway of signal 
transduction mediated by the GPI anchored proteins or 
GPI anchors is not known. One hypothetical view is 
that the extracellular phosphatidylinositol (PI) or GPI 
anchors are hydrolysed by endogenous PI-specific 
phospholipase C (PIPLC) [9] or GPI-specific PLC [lo] 
which would generate second messengers [l-33. The 
question, however , arises of whether the second mes- 
sage produced at the outer surface of the cell would 
actually transmit he signal intracellularly. Here we ad- 
dressed this basic question by use of bacterial PIPLC. 
The results show that digestion with bacterial PIPLC of 
PI or GPI anchors on the external surface of the cell 
Abbreviatiorts: GPI, 8lycosylphosphatidylinositol; IP, inositol phos- 
phate; PIPLC. phosphatidylinositol-specific phospholipase C; DG, 
diocyl(diradyl)8lycerol. 
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does induce the intracellular signal or signals which 
cooperate with the TCRXDZinduced signal into mur- 
ine thymocytes. 
2. MATERIALS AND METHODS 
2. I. Ceils and reugcm 
Single cell suspensions of thymocytes in Eade’s MEM were pre- 
pared from C57RW6 mice as described [I 11. MAb specific to CD3 
(145.2Cl I, l:l,OOO ofasciteseacept o herwise noted)andc:oss-linkin 
anti-18 (1:50) [6] were used. PIDLC was prepared from thesupcr%tant 
of a culture of B. rhtrr~giens&s as described [12]. This highly purified 
PIPLC gave a single band in SDS-PAGE and was protease-fiec. For 
some experiments PIPLC was removed from the PlPLCcontaining 
preparation by passing it through an anti-PIPLC affinity column. The 
anti-PIPLC column was prepared by use of an Immunoaffinity kit 
(Bib-Rad Laboratories, Richmond, CA, USA) and PlPLC-spcciBc 
purified rabbit I8G according to the procedure recommended bythe 
supplier. The column was confirmed to specifically adsorb all the 
enzyme activity to hydrolyze the GPI anchor. 
2.2. Asqv ojp~tosplroryrosine-conrainlng proreim 
Immunoblot assay of phosphotyrosinecontaining proteins was car- 
ried out as described [6,13] for the lysates of the cells (10’ ccllsQOO ~1) 
that had been treated or untreated with PIPLC and/or antXD3/anti- 
Ig. Specificity of the anti-phosphotyrosine a tibody used for devclop- 
ment of the phosphotyrosinecontaining proteins has been extensively 
studied and reported 119. Moreover, using phospbotyrosine, 
phosphoserine and phosphothreonine as inhibitors [6] WC confirmed 
that all the bands we demonstrated were phosphotyrosinc-containing 
proteins. 
2.3. RNA preparation and Nor&hem blot anufysis 
Total eellulor RNA was prepared by a single-step method and its 
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Northern blot analysis was carried out as described [14]. The DNA 
probe used in this study was a 2.4 kb BarnHl-SuiI fragment of mouse 
c-fis cDNA [IS]. 
2.4. Assuy of DNA synrhcsis 
Thymocytcs (lo6 cells/well) were cultured in 96-well issue culture 
plates containing 200 /&well of RPlvll tissues culture medium with 
10% FCS [ 1 I]. To assess DNA synthesis, 37 KBqlwcll [“H]thymidine 
was added during the last 4 h. After harvesting the cells on filter paper 
the radioactivity (cpm) was determined by liquid scintillation count- 
ing. 
3. RESULTS AND DISCUSSION 
Stimulation of murine thymocytes with anti-CD3 
mAb or anti-CD3 mAb plus cross-linking anti-Ig in- 
duced low levels of increase in tyrosine phosphorylation 
of 110, 92, 80 and 40 kDa proteins as the very early 
siycsl for T cell activation [6,16,17]. The tyrosine phos- 
phorylation of these proteins was definitely promoted 
by treating the cells previously with PlPLC, and the 
promotion was most evident for the 40 kDa protein, 
The intensification by PIPLC was most evident as early 
as 2 min after anti-CD3 stimulation (Expt. 2 in Fig. 1). 
Although data are not shown treatment with PIPLC 
alone without anti-CD3 stimulation was barely active. 
A concentration of 30 mu/ml was enough either for full 
promotion of signal transduction or for the maximum 
cleaving of PIPLC-sensitive Thy-l from the ihynlocytes 
(not shown). 







bation with PIPLC and its continuous presence during 
anti-CD3 stimulation were needed (compare lane 4 with 
lane 3), although pre-incubation alone (lane 4) was par- 
tially effective. It could be that IP glycan-linked proteins 
released uring the necessary pre-incubation time acted 
as the second messenger of the PIPLC activity. The 
culture supernatant of the PIPLC-treated thymocytes, 
which contained both the IP glycan-linked proteins and 
PIPLC, actually promoted the signal delivery (lane 3 in 
Fig. 2B). However, when the culture supernatant of the 
PIPLC-treated thymocytes (lane 5) or the original 
PIPLC solution (lane 4 in Fig. 2B) was passed through 
an anti-PIPLC antibody affinity column it lost all the 
activity to promote the protein tyrosine phosphoryla- 
tion (compare with lane 3). This result argued against 
the above mentioned view, and further confirmed the 
close association of the activity with PIPLC. 
Fig. 3 demonstrates an extensive acceleration of tran- 
scription of c-j& as an immediate early gene for cell 
growth response [ 181, which occurred following the aug- 
mented protein tyrosine phosphorylation in the PIPLC- 
treated and anti-CD3-stimulated thymocytes. DNA 
synthesis was actually promoted in these cells at the 
peak level attained in the culture 2 days after stimula- 
tion (Fig. 4). The latter result did not agree with the 
earlier report by Presky et al. [19], who failed :o demon- 
strate such an effect with PIPLC from S. nureus. The 
apparent discrepancy between their and our data is 







Fig. 1. Promotion by PIPLC of anti-CD3 mAb-induced protein tyrosinc phosphorylation. (Experiment 1) Thymoc>:cs were first treated (lanes 3 
and 6) or untreated (lanes 2 and 5) with PIPLC (IS0 mu/ml) for I h and were then stimulated with anti-CD3 alone (lanes 2 and 3) or anti-CD3 
plus cross-linking anti-16 at an interval of 1 min (lanes 5 and 6). Cells were incubaled at 37OC for _ 7 min after stimulation. Lanes I and 4 show 
no anti-CD3 control, (Experiment 2) Thymocytes previously treated (lanes 4-6) or untreated (lanes l-3) with PIPLC (150 mu/ml) for 30 min were 
stimulated with anti-CD3 plus anti-Ig and incubated for 2 (lanes I and 4), 5 (lanes 2 and 5) and 10 (lanes 3 and 6) min, Ceils were then lysecl for 
immunoblot assay of phosphotyrosine-containing proteins, Approximalc molecular sizes (in kDa) are shown on the left, The heavy band just below 
the 56 kDa protein corresponds to IgG heavy chain stained with [lz51]protein A. Basically the same results were obtained in 5 additional experiments 
in which thymocytes were stimulated with variable concentrations (1:500-1:5,000) of antiCD3. 
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GPI anchors of PIPLC from B, thuringiensis than that 
in S. aweus [20]. 
We conclude from these results that the hydrolysis of 
PI or GPI anchors of membrane proteins at the external 
surface of the cell with exogenous PIPLC does deliver 
an accessory signal into thymocytes, which modulates 
the TCRKZD34nduced signal for cell activation. Be- 
cause the bacterial PIPLC hydrolyses both PI and GPI 
anchors of membrane proteins the mechanism of the 
PIPLC-mediated signal modification also involves ei- 
ther (or both) of the two pathways through hydrolysis 
of PI or GPI anchors. Nevertheless, it is possible that 
the known signaling through cross-linking GPI-an- 
chored proteins [5-81 at least in part involves a similar 
pathway, possibly activated by endogenous PIPLC [9] 
or GPI-specific PLC [lo]. Whether or not this hypothct- 
ical view may be the case our result would suggest a 
novel host-parasite relationship whereby microorgan- 
isms modulate the receptor-mediated intracellular sig- 
nal delivery of mammalian cells by releasing surface- 
acting PIPLC, which possibly associates with the patho- 




Fig. 2. Requirements for PIPLC-mediated sifgnal promotion. (A) Thy- 
moeytcs were treated (lanes 3 and 4) or untreated (lanes 2 and 5) with 
PIPLC (30 mu/ml) for I h. They wcrc washed twice with MEM, and 
then stimulated by anti-CD3 plus anti-IS in the presence (lanes 3 and 
5) or absence (lanes 2 and 4) of freshly added PIPLC (30 mUmI). Lane 
1 shows the no antibody control. (B) Solution of PIPLC (60 mu/ml: 
and supcmatant of culture of the thymocytes that had been incubatco 
with PIPLC (a0 mu/ml) at 37°C for I h (‘culture supmatant’) were 
passed through anti-PIPLC afiinity columns and the effluents were 
ndjustcd to the volumes of the original preparations. Fresh thymoeytes 
were treated for 30 min with the previously prepared culture supma- 
tant (lane 3), the anti-PIPLC column-passed culture supmatant (lane 
S), or the anti-PIPLC column-passed PIPLC solution (lane 4). These 
cells and untreated control eclls (lane 2) were then stimulated with 
anti-CD3 plus anti-16 for 2 min. and were lyscd for immunoblot assay 
of phosphotyrosine containinS proteins. Only the data nround the 40 
DoYS 
Fig. 4. Augmentation by PIPLC of anti-CD3 mAb-induced DNA 
synthesis. Thymoeytcs were first treated (0. A) or untrcatcd (0. A) with 
PIPLC (I 50 mu/ml) for 30 min and then stimulated (0. l ) or unstim- 
ulatcd (A. A) with anti-CD3 (I:5,03oj for sueeessivc culture. Their 
proliferation response was tested by [‘Wlhymidinc uptake. Each point 
shows the mcah of triplicate oul:ures with SD. The dil%rcnee in the 
values determined on day 2 (0.0) was statistiealiy sigGant (P -Z 0,Ol 
by Student’s r-test). Basically the same results were obtained in 6 
and 56 kDa proteins are shown. additional similarly designed expcrimcnts. 
2.2kb- 
12 3 4 
Fig. 3. Acceleration by PIPLC of anti-CD3 mAb-lnduecd c-fos tmn- 
serlption. Total cellular RNA was extracted from control thymoeytcs 
(lane I), thymocytcs treated with PIPLC (150 mu/ml for 30 min) alone 
(lane 2). thymocytes stimulated with anti-CD3 alone (lane 3) or thy- 
moeytes first treated with PIPLC and then stimulated with anti-CD3 
(lane 4). Hybridization was done with a mouse c-Jx-spceific probe. 
The size of the transcript is shown on the lefi side. Ethidium bromide 
staining of the gel containing 28 S and 18 S RNAs is shown below to 
indicate qual loading. 
We failed to demonstrate any second messenger ac- 
tivity in the fraction containing the PIPLC-released sol- 
uble factors such as IP glycan-linked proteins (Fig. 2B). 
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It is, therefore, likely that diacylglycerol or diradylgly- 
ccc01 (DG) with potentially variable fine structures [l- 
31, which was produced after hydrolysis of PI and/or 
GPI anchors of membrane proteins with bacterial 
PIPLC, worked as a second messenger, possibly inter- 
nalized [9] for activating some isoform of protein kinase 
C [21,22]. This conclusion might well correspond to the 
recei;: observation by Diaz-Laviada et al. [23] that the 
treatment of Swiss 3T3 fibroblasts with B. dturingiertsis 
PIPLC provoked the translocation and activation of 
protein kinase C through production of DG. However, 
activation of protein kinase C by DG may not directly 
explain the pathway for augmented protein tyrosine 
phosphorylation observed in our experiment. A recent 
study showed that Thy-l and other GPI-anchored 
membrane proteins are associated with a tyrosine ki- 
nase ~56”~ 1241. The signal cascade triggered by PIPLC 
might therefore involve the functional modification of 
p561ck, possibly through its serine phosphorylation by 
the DG-activated C-kinase [25], which in turn phospho- 
rylates some distinguished substrates at tyrosine. 
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